Other
2027
Medtronic 2027 increased by 0.1% to $1.61B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 2.4%, from $1.65B to $1.61B. This increase may warrant attention — for this metric, lower values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionOther
CategoryProfitability
SignalLower is better
VolatilityStable
First reportedQ3 2016
Last reportedQ3 2026Feb 24, 2026
How to read this metric
Lower projected expenses indicate a reduction in the drag on future net income as assets become fully amortized.
Detailed definition
This represents the projected amortization expense for finite-lived intangible assets for the year 2027. These assets ty...
Peer comparison
Standard disclosure for banks with significant historical acquisition activity.
Metric ID:
other_finite_lived_intangible_assets_amortization_expens_a31c97Historical Data
15 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.65B | $1.66B | $1.66B | $1.65B | $1.65B | $1.65B | $1.65B | $1.66B | $1.66B | $1.63B | $1.64B | $1.65B | $1.61B | $1.61B | $1.61B |
| QoQ Change | — | +0.6% | -0.1% | -0.8% | +0.0% | +0.2% | +0.1% | +0.2% | +0.4% | -2.3% | +0.8% | +0.5% | -2.6% | +0.1% | +0.1% |
| YoY Change | — | — | — | -0.3% | -0.9% | -0.6% | +0.3% | +0.5% | +0.7% | -1.7% | -1.1% | -1.0% | -1.3% | -2.0% | -2.4% |
Range$1.61B – $1.66B
CAGR-0.8%
Avg YoY Growth-0.8%
Median YoY Growth-0.9%
Current Streak2 quarters growth
2027 at Other Companies
Frequently Asked Questions
- What is Medtronic's 2027?
- Medtronic (MDT) reported 2027 of $1.61B in Q4 2025.
- How has Medtronic's 2027 changed year-over-year?
- Medtronic's 2027 decreased by 2.4% year-over-year, from $1.65B to $1.61B.
- What does 2027 mean?
- The expected non-cash expense for acquired intangible assets in the year 2027.